Aethlon Medical Inc (AEMD)

[Truthteller]

Sector Update: Health Care Stocks Edging Higher; Aethlon Medical Jumps After FDA Approves Filter Use With Ebola Patients
MIDNIGHT TRADER 1:18 PM ET 1/2/2015
Symbol Last Price Change
AEMD 0.327down +0.0595 (+22.24%)
QUOTES AS OF 02:47:30 PM ET 01/02/2015
01:18 PM EST, 01/02/2015 (MT Newswires) -- Top Health Care Stocks

JNJ -0.06%

PFE +0.64%

ABT -0.51%

MRK +0.83%

AMGN +0.19%
Health care stocks were narrowly higher today with the NYSE Health Care Sector Index climbing 0.1% and shares of health care companies in the S&P 500 ahead 0.2% as a group.

In company news, Aethlon Medical Inc(AEMD) surged Friday after U.S. regulators approved testing of its bio-filtration device in Ebola patients after a critically ill patient in Germany who was treated using the device recovered from the deadly virus.

The device filters viruses and toxins from the blood. It currently is being tested in India for its ability to accelerate viral load depletion when used in combination with hepatitis C standard-of-care drug therapy.

Under the new U.S. Food and Drug Administration approval, up to 20 patients in this country will be treated for six to eight hours daily with the Hemopurifier until the Ebola viral load drops below 1,000 copies per milliliter.

AEMD shares were up nearly 20% at 32 cents apiece, just 2 cents under its session high. The stock has traded within a 52-week range of 10 cents to 72 cents a share, already climbing 35% over the past year prior to today's gain.